LINDE PLC logo

LINDE PLC

LIN
Industrial Inorganic Chemicals
Last filing · Quarter 2 · Jun 30, 2026
Format
% Change
Rows
USD ($)
$ in Millions
Jun 30, 2026Mar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Sep 30, 2022Jun 30, 2022Mar 31, 2022Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020Mar 31, 2020Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Sep 30, 2017
Assets
                         
Consolidated Balance Sheets [Abstract]
                         
Cash and cash equivalents
4,898
3,959
4,509
4,786
5,294
5,187
4,626
4,848
3,894
3,357
4,962
3,756
Accounts receivable - net
5,632
5,321
5,331
5,230
4,950
4,871
5,001
5,009
4,692
4,799
4,753
4,599
Contract assets
432
321
228
260
293
255
226
217
151
156
175
104
Inventories
2,122
2,079
2,128
2,122
1,984
2,087
2,094
2,100
2,078
2,079
2,054
1,855
Assets held for sale
-
-
-
-
-
-
-
-
-
-
-
-
Prepaid and other current assets
1,092
1,071
1,135
1,229
1,076
1,060
896
928
922
1,020
960
889
Total Current Assets
14,176
12,751
13,331
13,627
13,597
13,460
12,843
13,102
11,737
11,411
12,904
11,203
Property, plant and equipment - net
29,170
28,564
27,535
26,928
25,710
25,124
24,575
24,418
23,624
23,808
23,796
22,586
Goodwill
27,927
27,882
27,828
27,812
26,507
27,108
26,365
26,289
25,955
26,456
26,418
24,565
Other intangible assets - net
11,564
11,673
11,931
12,082
11,561
12,113
11,851
12,001
12,092
12,510
12,638
11,810
Other long-term assets
5,512
5,445
5,368
5,629
5,329
4,741
4,581
4,537
4,419
4,533
4,552
4,159
Total Assets
88,349
86,315
85,993
86,078
82,704
82,546
80,215
80,347
77,827
78,718
80,308
74,323
Liabilities and Equity
                         
Accounts payable
2,837
2,659
2,646
2,593
2,446
2,845
2,859
2,885
2,750
2,977
2,941
3,067
Short-term debt
4,861
4,822
4,962
4,879
4,465
3,509
3,326
4,046
3,849
3,018
5,337
3,179
Current portion of long-term debt
2,474
1,636
2,371
1,340
1,824
1,278
1,261
1,046
922
944
1,696
1,551
Contract liabilities
1,128
1,168
1,279
1,261
1,196
1,727
1,767
1,827
1,985
3,246
3,070
2,902
Liabilities of assets held for sale
-
-
-
-
-
-
-
-
-
-
-
-
Other current liabilities
4,827
5,106
4,934
4,641
4,554
4,690
4,291
4,585
4,656
4,367
4,741
4,362
Total Current Liabilities
16,127
15,391
16,192
14,714
14,485
14,049
13,504
14,389
14,162
14,552
17,785
15,061
Long-term debt
20,678
19,859
18,592
19,701
17,608
17,475
16,931
15,227
13,232
13,528
11,744
10,608
Other long-term liabilities
10,914
10,973
11,123
11,677
11,148
10,419
10,229
10,502
10,195
9,390
9,443
9,715
Total Liabilities
47,719
46,223
45,907
46,092
43,241
41,943
40,664
40,118
37,589
37,470
38,972
35,384
Redeemable noncontrolling interests
13
13
13
13
13
13
13
13
13
13
13
13
Linde plc Shareholders’ Equity (Note 10):
                         
Accrued liabilities
-
-
-
-
-
-
-
-
-
-
-
-
Related party debt (Note 7)
-
-
-
-
-
-
-
-
-
-
-
-
Ordinary shares, €0.001 par value, authorized 1,750,000,000 shares, 2026 and 2025 issued: 490,766,972 ordinary shares
1
1
1
1
1
1
1
1
0
0
0
1
Additional paid-in capital
39,130
39,177
39,405
39,411
39,408
39,573
39,560
39,570
39,803
39,797
39,859
40,011
Receivable from shareholders
-
-
-
-
-
-
-
-
-
-
-
-
Retained earnings
18,804
17,639
15,796
14,595
13,545
11,585
10,721
9,708
7,940
7,024
6,092
19,845
Accumulated other comprehensive income (loss)
(5,926)
(6,147)
(6,409)
(6,250)
(6,768)
(6,059)
(6,794)
(6,528)
(6,676)
(5,899)
(5,810)
(8,094)
Less: Treasury shares, at cost (2026 – 29,786,809 shares and 2025 – 27,086,030 shares)
12,928
12,104
10,177
9,242
8,154
5,927
5,309
3,922
2,169
1,011
171
14,135
Total Linde plc Shareholders’ Equity
39,081
38,566
38,616
38,515
38,032
39,173
38,179
38,829
38,898
39,911
39,970
37,628
Noncontrolling interests
1,536
1,513
1,457
1,458
1,418
1,417
1,359
1,387
1,327
1,324
1,353
1,298
Total Equity
40,617
40,079
40,073
39,973
39,450
40,590
39,538
40,216
40,225
41,235
41,323
38,926
Total Liabilities and Equity
88,349
86,315
85,993
86,078
82,704
82,546
80,215
80,347
77,827
78,718
80,308
74,323
Common stock, par value (euro per share)
-
-
-
-
-
-
-
-
-
-
-
-
Statement [Line Items]
                         
Common stock, authorized (in shares)
-
-
-
-
-
-
-
-
-
-
-
-
Common stock, issued (in shares)
-
-
-
-
-
-
-
-
-
-
-
-